vs

Side-by-side financial comparison of CENTRUS ENERGY CORP (LEU) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $146.2M, roughly 1.3× CENTRUS ENERGY CORP). On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -3.6%). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 6.5%).

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

LEU vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.3× larger
NEO
$186.7M
$146.2M
LEU
Growing faster (revenue YoY)
NEO
NEO
+14.7% gap
NEO
11.1%
-3.6%
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LEU
LEU
NEO
NEO
Revenue
$146.2M
$186.7M
Net Profit
$-108.0M
Gross Margin
23.9%
43.3%
Operating Margin
8.8%
46.9%
Net Margin
-57.9%
Revenue YoY
-3.6%
11.1%
Net Profit YoY
42.0%
EPS (diluted)
$0.52
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEU
LEU
NEO
NEO
Q1 26
$186.7M
Q4 25
$146.2M
$190.2M
Q3 25
$74.9M
$187.8M
Q2 25
$154.5M
$181.3M
Q1 25
$73.1M
$168.0M
Q4 24
$151.6M
$172.0M
Q3 24
$57.7M
$167.8M
Q2 24
$189.0M
$164.5M
Net Profit
LEU
LEU
NEO
NEO
Q1 26
$-108.0M
Q4 25
Q3 25
$3.9M
$-27.1M
Q2 25
$28.9M
$-45.1M
Q1 25
$27.2M
$-25.9M
Q4 24
Q3 24
$-5.0M
$-17.7M
Q2 24
$30.6M
$-18.6M
Gross Margin
LEU
LEU
NEO
NEO
Q1 26
43.3%
Q4 25
23.9%
43.8%
Q3 25
-5.7%
42.8%
Q2 25
34.9%
42.6%
Q1 25
45.0%
43.6%
Q4 24
40.8%
44.9%
Q3 24
15.4%
44.6%
Q2 24
19.3%
44.1%
Operating Margin
LEU
LEU
NEO
NEO
Q1 26
46.9%
Q4 25
8.8%
-7.1%
Q3 25
-22.2%
-14.4%
Q2 25
21.7%
-26.3%
Q1 25
28.0%
-16.6%
Q4 24
29.7%
-10.7%
Q3 24
-13.2%
-12.6%
Q2 24
11.2%
-13.3%
Net Margin
LEU
LEU
NEO
NEO
Q1 26
-57.9%
Q4 25
Q3 25
5.2%
-14.4%
Q2 25
18.7%
-24.9%
Q1 25
37.2%
-15.4%
Q4 24
Q3 24
-8.7%
-10.5%
Q2 24
16.2%
-11.3%
EPS (diluted)
LEU
LEU
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.52
Q3 25
$0.19
Q2 25
$1.59
Q1 25
$1.60
Q4 24
$3.26
Q3 24
$-0.30
Q2 24
$1.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEU
LEU
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$2.0B
$146.1M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$765.1M
$828.8M
Total Assets
$2.4B
$1.3B
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEU
LEU
NEO
NEO
Q1 26
$146.1M
Q4 25
$2.0B
$159.6M
Q3 25
$1.6B
$164.1M
Q2 25
$833.0M
$154.7M
Q1 25
$653.0M
$346.2M
Q4 24
$671.4M
$367.0M
Q3 24
$194.3M
$362.0M
Q2 24
$227.0M
$355.1M
Total Debt
LEU
LEU
NEO
NEO
Q1 26
Q4 25
$1.2B
$341.9M
Q3 25
$1.2B
Q2 25
$390.0M
Q1 25
$389.5M
Q4 24
$472.5M
$541.1M
Q3 24
$83.5M
Q2 24
$86.5M
Stockholders' Equity
LEU
LEU
NEO
NEO
Q1 26
$828.8M
Q4 25
$765.1M
$836.6M
Q3 25
$363.1M
$838.3M
Q2 25
$359.1M
$854.0M
Q1 25
$213.9M
$888.3M
Q4 24
$161.4M
$902.3M
Q3 24
$76.4M
$908.2M
Q2 24
$76.6M
$915.9M
Total Assets
LEU
LEU
NEO
NEO
Q1 26
$1.3B
Q4 25
$2.4B
$1.4B
Q3 25
$2.2B
$1.4B
Q2 25
$1.3B
$1.4B
Q1 25
$1.3B
$1.6B
Q4 24
$1.1B
$1.6B
Q3 24
$591.0M
$1.6B
Q2 24
$668.2M
$1.6B
Debt / Equity
LEU
LEU
NEO
NEO
Q1 26
Q4 25
1.54×
0.41×
Q3 25
3.23×
Q2 25
1.09×
Q1 25
1.82×
Q4 24
2.93×
0.60×
Q3 24
1.09×
Q2 24
1.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEU
LEU
NEO
NEO
Operating Cash FlowLast quarter
$-48.4M
$-8.1M
Free Cash FlowOCF − Capex
$-58.0M
FCF MarginFCF / Revenue
-39.7%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$31.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEU
LEU
NEO
NEO
Q1 26
$-8.1M
Q4 25
$-48.4M
$1.3M
Q3 25
$10.1M
$8.9M
Q2 25
$52.8M
$20.3M
Q1 25
$36.5M
$-25.3M
Q4 24
$57.9M
$9.8M
Q3 24
$-33.2M
$9.2M
Q2 24
$7.0M
$13.9M
Free Cash Flow
LEU
LEU
NEO
NEO
Q1 26
Q4 25
$-58.0M
$-6.5M
Q3 25
$5.7M
$570.0K
Q2 25
$49.2M
$14.0M
Q1 25
$34.4M
$-29.8M
Q4 24
$57.2M
$-1.8M
Q3 24
$-34.2M
$-1.6M
Q2 24
$6.1M
$814.0K
FCF Margin
LEU
LEU
NEO
NEO
Q1 26
Q4 25
-39.7%
-3.4%
Q3 25
7.6%
0.3%
Q2 25
31.8%
7.7%
Q1 25
47.1%
-17.8%
Q4 24
37.7%
-1.0%
Q3 24
-59.3%
-0.9%
Q2 24
3.2%
0.5%
Capex Intensity
LEU
LEU
NEO
NEO
Q1 26
Q4 25
6.6%
4.1%
Q3 25
5.9%
4.4%
Q2 25
2.3%
3.5%
Q1 25
2.9%
2.7%
Q4 24
0.5%
6.7%
Q3 24
1.7%
6.4%
Q2 24
0.5%
8.0%
Cash Conversion
LEU
LEU
NEO
NEO
Q1 26
Q4 25
Q3 25
2.59×
Q2 25
1.83×
Q1 25
1.34×
Q4 24
Q3 24
Q2 24
0.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

NEO
NEO

Segment breakdown not available.

Related Comparisons